Avelumab/Gemcitabine in Sarcomatoid RCC
Clinical trial NCT03483883 · TERMINATED
Trial details
- NCT number
- NCT03483883
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-03-19
- Primary completion
- 2020-07-22
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.